Potent antitumor effect of combination therapy with sub‑optimal doses of Akt inhibitors and pomalidomide plus dexamethasone in multiple myeloma.

MLA

Kinoshita, Shiori, et al. “Potent Antitumor Effect of Combination Therapy with Sub‑optimal Doses of Akt Inhibitors and Pomalidomide plus Dexamethasone in Multiple Myeloma.” Oncology Letters, vol. 15, no. 6, June 2018, pp. 9450–56. EBSCOhost, https://doi.org/10.3892/ol.2018.8501.

APA

Kinoshita, S., Ri, M., Kanamori, T., Aoki, S., Yoshida, T., Narita, T., Totani, H., Ito, A., Kusumoto, S., Ishida, T., Komatsu, H., & Iida, S. (2018). Potent antitumor effect of combination therapy with sub‑optimal doses of Akt inhibitors and pomalidomide plus dexamethasone in multiple myeloma. Oncology Letters, 15(6), 9450–9456. https://doi.org/10.3892/ol.2018.8501

Chicago

Kinoshita, Shiori, Masaki Ri, Takashi Kanamori, Sho Aoki, Takashi Yoshida, Tomoko Narita, Haruhito Totani, et al. 2018. “Potent Antitumor Effect of Combination Therapy with Sub‑optimal Doses of Akt Inhibitors and Pomalidomide plus Dexamethasone in Multiple Myeloma.” Oncology Letters 15 (6): 9450–56. doi:10.3892/ol.2018.8501.